Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 438 results for "pfizer"

Inside Track: Behind the scenes of the Pfizer and Astrazeneca ...

IT WAS ever thus: investment bankers kick off the year talking up a economic environment ripe for throwing up industry-defining mergers and acquisitions. By Easter, theyre conjuring up myriad reasons why said deluge of deals has failed to ... Yahoo! UK and Ireland, 4 hours ago

1,074 images for pfizer, 1 day ago
92.9 WLMI, 2 days ago
Money Today, 2 days ago
Pharma Times, 1 day ago
Pharma Times, 2 days ago
Irish Times, 21 hours ago
Financial Express, 3 days ago
92.9 WLMI, 3 days ago
BusinessWeek, 2 days ago
1440 WNFL, 2 days ago
Jutia Group

Encouraging Results from Pfizer's Xeljanz

Pfizer Inc. ( PFE ) announced encouraging top-line results from two pivotal phase III studies from the Oral treatment Psoriasis Trials (:OPT) Program (OPT Pivotal #1 and OPT Pivotal #2) on Xeljanz (tofacitinib:5mg and 10mg). Xeljanz, an oral Janus ...
 Yahoo! Finance7 hours ago Pfizer Announces Positive Results From Two Phase 3 Trials Of Tofacitinib  RTTNews.com1 day ago Pfizer announces encouraging results from two Phase III psoriasis trials  PredictWallStreet18 hours ago Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis  News-Medical.Net1 day ago
Pharmaceutical Technology

Pfizer may bid again for AstraZeneca

US-based Pfizer may push ahead with a second approach for the takeover of UK-based AstraZeneca after the company reportedly rejected its initial £60bn ($101bn) bid. Pfizer may approach AstraZeneca for the takeover as the company is currently ...
 Pharmaceutical Technology9 hours ago 4 AstraZeneca reportedly rejects £60bn approach from Pfizer  Irish Times9 hours ago M&A activity in pharmaceuticals pushes UK's FTSE higher  Yahoo! UK and Ireland1 day ago Pfizer may return for AstraZeneca after initial approach  Irish Times1 day ago
Lawyers & Settlements

Settlement: Pfizer to Pay $190M in Neurontin Class Action Settlement

New York, NY: A $190M settlement has been reached in a consumer fraud class action lawsuit pending against Pfizer which alleges the pharma giant engaged in tactics to delay market entry of generic versions of its epilepsy drug Neurontin. The ...
 Lawyers & Settlements13 hours ago Pfizer held talks with AstraZeneca: Reports  CNBC1 day ago Pfizer agrees to $190 mn settlement over generic versions of its epilepsy drug  Business Standard India2 days ago Pfizer agrees to US$190mil settlement over generic neurontin days ago

Pfizer complains about India’s IPR regime again

, ET Bureau | 23 Apr, 2014, 05.04PM IST Post a Comment PFizer has complained about India’s intellectual property regime yet again. NEW DELHI: US pharma giant Pfizer Inc has complained about India's intellectual property regime yet again, this time to ...
 Economic Times17 hours ago Pfizer complains about India's intellectual property regime again  Economic Times17 hours ago
This is Money

ALEX BRUMMER: Vince Cable should take up cudgels against Pfizer bid for AstraZeneca

The main market interest in GlaxoSmithKline in recent days has been in the growing list of alleged bribery overseas. Chief executive Sir Andrew Witty will welcome the distraction of a bit of deal-making with Swiss rival Novartis. Of more ...
 This is Money21 hours ago ALEX BRUMMER: Cable should oppose Pfizer bid for AstraZeneca  This is Money22 hours ago

Drug offers breast cancer hope

Washington - An experimental cancer drug made by Pfizer has shown signs of promise at slowing the spread of advanced breast cancer, researchers said. The drug, called palbociclib, when administered with another anti-cancer drug already on the ...
 IOL17 hours ago Promise seen with Pfizer breast cancer drug  Business Standard2 weeks ago Pfizer Drug Shows Promise in Slowing Down Breast Cancer Progression  Med India2 weeks ago Experimental breast cancer drug shows promising results, Pfizer says  Times of India2 weeks ago

Accuretic hit by supply problems, reports Pfizer

Please note: The comment facility allows users to post directly to the site - comments are not moderated and do not necessarily reflect the views of C+D or any of its employees or authors. We accept no responsibility, legal or otherwise, for ...
 Chemist+Druggist12 hours ago
MedCity News

Pfizer to seek approval for psoriasis drug [The Day, New London, Conn. :: ]

April 23--Pfizer Inc Pfizer said results from two late-stage trials of tofacitinib, which has been approved by the U.S. Food and Drug Administration under the name Xeljanz as a treatment for rheumatoid arthritis, show that the drug greatly reduces ...
 BusinessWeek21 hours ago Can Pfizer build a better psoriasis treatment with rheumatoid arthritis drug?  MedCity News16 hours ago
This is Money

British jobs at risk as AstraZeneca faces takeover bid by Pfizer

Thousands of British science jobs could be at risk after one of the UK's biggest pharmaceuticals companies was embroiled in a £170billion foreign takeover battle. AstraZeneca, which develops cancer and diabetes drugs, almost fell prey to Pfizer, ...
 This is Money22 hours ago Thousands of British jobs at risk as AstraZeneca faces takeover battle with US drugs giant Pfizer  This is Money21 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pfizer
Get updated on latest news & your favorite topics right in your inbox!
More     Less